BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 22, 2002
View Archived Issues
Lundbeck Acquiring Synaptic, CNS Pipeline For $121M In Cash
Synaptic Pharmaceutical Corp. signed a definitive merger agreement with like-minded central nervous system-focused H. Lundbeck A/S in a deal worth about $121 million. (BioWorld Today)
Read More
Jun Gene Encodes Enzyme That Links Obesity, Diabetes In Tissue Inflammation With Drug Designs
Read More
Inspire Starts Phase III Trial Of Drug For Allergic Rhinitis
Read More
Other News To Note
Read More
Inflazyme In Line For Up To $90M After Expanding Deal With Aventis
Read More